Welcome to our dedicated page for Acadia Healthcar SEC filings (Ticker: ACHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to spot how a Medicaid rate change or a new hospital acquisition might impact Acadia Healthcare (ACHC) can mean wading through hundreds of pages of legal and clinical detail. Add Form 4 footnotes on executive stock sales and the puzzle becomes even tougher.
Stock Titan solves that problem. Our AI reads every Acadia Healthcare quarterly earnings report 10-Q filing, annual report 10-K, and 8-K material event the moment it hits EDGAR, then translates dense language into clear takeaways—bed-count trends, payer-mix shifts, EBITDA drivers. Real-time alerts flag Acadia Healthcare Form 4 insider transactions so you never miss meaningful buying or selling.
Wondering where to locate acquisition pipelines or facility occupancy data? Our platform groups filings by topic and adds plain-English summaries, letting you jump straight to revenue segmentation tables, covenant disclosures, or that elusive footnote on regulatory settlements. It’s Acadia Healthcare SEC filings explained simply.
- Track Acadia Healthcare insider trading Form 4 transactions in real time.
- Compare margins across facilities using AI-tagged sections of each 10-Q.
- Dive into the proxy statement executive compensation without reading 80 pages.
- Receive instant context when an 8-K material events explained notice is posted.
From earnings report filing analysis to monitoring executive stock transactions Form 4, Stock Titan streamlines the workflow. Stop combing through exhibits—start understanding Acadia Healthcare SEC documents with AI and make faster, better-informed decisions.
Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.
Wellington Management and related entities report beneficial ownership of 8,430,343 shares of Acadia Healthcare Company, Inc. common stock, representing approximately 9.15% of the class. The filing shows no sole voting or dispositive power; instead Wellington discloses shared voting power of 7,995,273 shares and shared dispositive power of 8,430,343 shares. The ownership is held of record by clients of Wellington’s investment advisers rather than by Wellington as a principal.
The filing identifies multiple Wellington entities as reporting persons, including entities classified as holding companies (HC) and investment advisers (IA). The filing also names the Vanguard Health Care Fund as an exception noted in the list of clients, without specifying a percentage for that fund.
FAQ
What is the current stock price of Acadia Healthcar (ACHC)?
What is the market cap of Acadia Healthcar (ACHC)?
